Sonova Holding (OTCMKTS:SONVY) Given Consensus Recommendation of “Hold” by Analysts

Sonova Holding (OTCMKTS:SONVY) has been given a consensus recommendation of “Hold” by the seven analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has given a strong buy rating to the company.

A number of analysts have commented on the stock. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Friday, July 24th. Morgan Stanley raised shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. Finally, UBS Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd.

Sonova Trading Up 0.1%

OTCMKTS:SONVY opened at $54.47 on Thursday. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51. Sonova has a 1-year low of $42.26 and a 1-year high of $61.09. The stock has a fifty day simple moving average of $50.70 and a 200 day simple moving average of $49.72.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.